InvestorsHub Logo
Followers 21
Posts 1234
Boards Moderated 0
Alias Born 12/10/2010

Re: None

Saturday, 02/22/2014 12:51:49 PM

Saturday, February 22, 2014 12:51:49 PM

Post# of 700147
In September, Northwest Biotherapeutics activated the second site for a DCVax-Direct Phase I/II trial. The M.D. Anderson Cancer Centers in Houston and Orlando are performing the trial for solid, inoperable tumors, including ovarian, lung, colon, pancreatic, liver melanoma, head and neck, and other cancers. Results are expected by year’s end. DCVax activates dendritic cells, which are injected directly into the tumors to shrink their sizes. http://www.genengnews.com/insight-and-intelligence/ovarian-cancer-treatment-options-multiply/77899912 This was out last year but interesting to read!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News